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Since 2015, APIC and SHEA have worked together on multiple
projects and programs to advance the fields of infection prevention
and hospital epidemiology in areas where our missions and visions
overlap. These collaborative efforts have evolved from a working
arrangement into a true partnership, with shared visions of how
this close relationship between the 2 organizations can mirror
high-functioning, successful infection prevention programs.
Each year, APIC and SHEA convene 2 formal meetings of a joint
organizational task force composed of a subsegment of both boards,
1 meeting in person and 1 by conference call. These meetings help
keep the changing society leaders informed about the partnership
and on track tomeet goals. To keep themembership informed as well,
we continue to host an annual SHEA/APIC Presidents’ Webinar to
highlight the shared resources and ideas of our collaborative efforts
and to provide an opportunity for members to ask questions and
contribute ideas for future collaborations.
In 2019, SHEA and APIC again hosted a joint education session,
held first at the SHEA Spring Meeting in Boston, Massachusetts, in
April, and then at the APIC Annual Conference in Philadelphia,
Pennsylvania, in June. This year’s session was titled “SSI Prevention
Strategies: IP in theOR.”The sessions attracted packed crowds at both
conferences and featured the presidents of both organizations, Hilary
Babcock, MD, MPH, FIDSA, FSHEA and Karen Hoffmann, RN, MS,
CIC, FSHEA, FAPIC. These sessionswere great opportunities not only
to showcase our leadership to each other’s members but also to give
the presidents an opportunity to get to know each other better, which
has further strengthened the partnership.
This organizational partnership facilitates volunteer-level
collaboration linking key committees of the 2 associations. Since
2018, APIC has been represented on SHEA’s public policy commit-
tee and SHEA has been represented on APIC’s practice guidance
committee.
In December 2018, we enthusiastically launched the Joint APIC–
SHEA Leadership Development Program, hosted in Arlington,
Virginia. This innovative program brought together an elite
group of infection preventionists and healthcare epidemiologists
to participate in joint leadership training. The conference focused
on building and maintaining effective leadership of infection
prevention and antibiotic stewardship practices and partnerships
across their facilities. We look forward to hosting the second
Leadership Development Program conference in December 2019
and to building upon the success of the inaugural conference.
Each year, we monitor our partnership goals and assess our
progress and opportunities to learn how we can strategically
support each other. To that end, each organization’s president,
along with the chief staff officer, presents at an in-person board
meeting of the other organization each year. These presentations
provide the opportunity to talk about the respective organizations
as a whole and to stress the leadership and partnership efforts on a
broad scale so this partnership will continue to grow stronger.
In 2019, both boards approved a new joint award to recognize
key partners of our 2 organizations who have made significant life-
time contributions to the fields of infection prevention and control
and epidemiology. The award criteria and nomination process are
being developed now, with a launch date of 2020. This award will
reach a critical niche of people who have been active contributors
through both organizations and have transcended their roles to set
the field on a higher level.
Additionally, one of our partnership goals for the past few years
has been to meet with patient advocacy and consumer groups to
develop positive, trusting relationships and to work in partnership
around mutual infection prevention goals. Although both SHEA
and APIC continue to develop independent strategies to work with
individual patient safety organizations, we have united in promot-
ing vaccine safety and effectiveness. Both organizations are work-
ing on strong, independent statements, with mutual endorsement,
to provide additional support for this effort. We are also working
on joint materials to be used by healthcare workers, patients, and
patient groups to promote this messaging.
These collaborative efforts of SHEA and APIC are crucial to the
missions of each organization: to keep patients safe from infections
and to champion effective and efficient care that preserves antibiotics
for future generations. The partnership allows us each to amplify our
coremessage that science-based practices for epidemiology and infec-
tion prevention should be applied to policy and practice for the best
patient outcomes. In a world crowded with information, being able to
jointly take a stand and send a message is critical to current practi-
tioners and to the future growth of the field.
Together, our organizations seek to have an impact across the
continuum of care on infection prevention in diverse populations
in all settings by promoting appropriate policies and practices and
by encouraging allocation of adequate resources to infection pre-
vention and antimicrobial stewardship. This ongoing partnership
serves to prioritize the importance of avoiding healthcare-associated
infections for safe and positive health outcomes.We look forward to
working together in the years to come for continued improvements
in care and patient protection.
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